AMR
-
Targeted vaccines are needed to combat antimicrobial resistance
Ten million people — equivalent to approximately one-quarter of the Canadian population — are expected to die annually due to antimicrobial resistance (AMR) worldwide by 2050. Researchers in Dr. Manish Sadarangani’s lab at the Vaccine Evaluation Center at BC Children’s argue that targeted vaccines are needed to help reduce such loss of life.
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.
for media